Roscovitine (CYC202)

Catalog No.S1153 Synonyms: Seliciclib, R-roscovitine

For research use only.

Roscovitine (CYC202, Seliciclib, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.

Roscovitine (CYC202) Chemical Structure

CAS No. 186692-46-6

Selleck's Roscovitine (CYC202) has been cited by 103 publications

Purity & Quality Control

Choose Selective CDK Inhibitors

Other CDK Products

Biological Activity

Description Roscovitine (CYC202, Seliciclib, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.
Targets
CDK5/p35 [1]
(Cell-free assay)
Cdc2/CyclinB [1]
(Cell-free assay)
CDK2/CyclinA [1]
(Cell-free assay)
CDK2/CyclinE [1]
(Cell-free assay)
ERK2 [1]
(Cell-free assay)
0.16 μM 0.65 μM 0.7 μM 0.7 μM 14 μM
In vitro

Roscovitine displays high efficiency and high selectivity towards some cyclin-dependent kinases with IC50 of 0.65, 0.7, 0.7 and 0.16 μM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E and cdk5/p53, respectively. [1] Roscovitine reversibly inhibits the prophaselmetaphase transition in the micromolar range of starfish oocytes and sea urchin embryos, inhibits in vitro M-phase-promoting factor activity and in vitro DNA synthesis in Xenopus egg extracts, and suppresses the proliferation of mammalian cell lines with an average IC50 of 16 μM. [1] In mesangial cells, Roscovitine results in a dose-dependent reduction of CDK2 activity that at concentrations of 7.5, 12.5 and 25 mM, Roscovitine causes a 25, 50% and 100% decrease in CDK2 activity, respectively. [2] A recent study shows that Roscovitine inhibits cdk5 kinase activity, cell proliferation, multicellular development, and cdk5 nuclear translocation in Dictyostelium discoideum, without affecting the expression of cdk5 protein during axenic growth. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
LB771-HNC NXrnNolvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV3Hbpk2UUN3ME20PE46OjF{IN88US=> MnLSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
LB2241-RCC NV63eWExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\qfGlEPTB;NEiuOlIxOiEQvF2= MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
DU-4475 M{Pa[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHjROnlKSzVyPUS4MlQ6OzdizszN MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LB2518-MEL MkfaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mk\PTWM2OD12Nz6wOFQ5KM7:TR?= NHjsPJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H209 M1HxZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{jnRWlEPTB;NE[uNFEyPSEQvF2= NHTiPFA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
CGTH-W-1 NUfnWoF2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{CzfGlEPTB;NESuPVY6PyEQvF2= NGPjSlY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
MS-1 M3PiXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWTjPGVYUUN3ME20Nk45QTNizszN MojrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
GI-ME-N MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3f2WGlEPTB;NEKuOlY4OSEQvF2= MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
DG-75 NHTBbVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYDJR|UxRTR{Lk[1OFYh|ryP MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
MLMA Mo[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLSUIlSUUN3ME20Nk4zPzh5IN88US=> NYXyR4VVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
HT NGntc4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFTGfZVKSzVyPUSyMlAxOjhizszN MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LC-1F NWXhfmw2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWnJR|UxRTRzLkW3NFUh|ryP NIDDZXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H1882 M1PlXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGOwfldKSzVyPUSwMlU6QThizszN Ml34QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NTERA-S-cl-D1 MorqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIHNUZJKSzVyPUO5MlU5PDJizszN MonxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H345 Mk\XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjJWnlKSzVyPUO4MlkyODZizszN M1jSflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MONO-MAC-6 NInlNXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTN6LkK0O|ch|ryP Mny5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
RS4-11 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFnQRZlKSzVyPUO3MlcxPjlizszN M3rESlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ML-2 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkXYTWM2OD1|Nz62O|EzKM7:TR?= M2P4NFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
OPM-2 NYS2NYk1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmHXTWM2OD1|Nz6yPVQ6KM7:TR?= M{fhb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LU-139 NXj3UI5KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mm\WTWM2OD1|Nz6xPFU3KM7:TR?= NELidXg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
COLO-684 MofFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLISYp3UUN3ME2zO{4xOTJizszN M1rxWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MOLT-4 M4rBOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGXVfphKSzVyPUO2MlMzPzZizszN Mmm5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
TE-6 M2Ls[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV:0e4x3UUN3ME2zOk4{OjR4IN88US=> MmXwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
TE-441-T M{TGR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVLme5dIUUN3ME2zOk4yOTR6IN88US=> MmWwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
IMR-5 M3\MNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MljCTWM2OD1|NT6zNVM6KM7:TR?= MnrCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
K5 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF73c4VKSzVyPUO1MlA5PjFizszN MmPUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
TE-10 M2jUdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFn1OHVKSzVyPUO0Mlk1OjJizszN NWjsbJdwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H2141 M1vQW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDoWphKSzVyPUO0MlY2OzNizszN NYrIblhORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KGN NF3kNXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\JT2dKSzVyPUO0MlI2OjRizszN M37NS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LP-1 NFHFPWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkXrTWM2OD1|Mz64PVA5KM7:TR?= MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H64 Mk\nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mly4TWM2OD1|Mz64OVk4KM7:TR?= NYGwcII2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
RKO MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvJdnJ3UUN3ME2zN{42QTZ7IN88US=> NHrTR4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H526 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXPJR|UxRTN|LkS5N|Yh|ryP NXj0OldqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
GOTO M3:yUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVS4Wpp4UUN3ME2zNk46OTJ7IN88US=> NVHDclVXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
Calu-6 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXXJR|UxRTN{LkS3OFUh|ryP MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LOUCY MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTN{LkGyOVMh|ryP NXXGUnJ3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
SK-N-FI NF60W2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkfJTWM2OD1|MT63OVM2KM7:TR?= M2X6WlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
SIG-M5 NIflSYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2rCcWlEPTB;M{GuOlg{OyEQvF2= M2\CRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NKM-1 NG[zN|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnfrTWM2OD1|MT6xN|k4KM7:TR?= M4mxNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NCI-SNU-1 M4frRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVLIWmY5UUN3ME2zNU4yODV7IN88US=> NELLOZA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H82 NWKxRmdiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHnUVXpKSzVyPUOxMlAyOzVizszN NU\CUmlCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H510A MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn\hTWM2OD1|MD6wN|I6KM7:TR?= M1rrcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ES3 M4rkW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn7kTWM2OD1{OT65OVgzKM7:TR?= NXHwWmNJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
BB30-HNC M3f1Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF\oUo1KSzVyPUK5Mlk1QDNizszN MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KM12 M{\jR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MknyTWM2OD1{OT62NlM6KM7:TR?= NHX2[4g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
GI-1 M4rCO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTJ7LkCxNVMh|ryP MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NOS-1 M2m1cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3LuWmlEPTB;MkiuPVc{OyEQvF2= NYfIZ5FQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TE-8 Mn;5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{fnT2lEPTB;MkiuPVA5KM7:TR?= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
TE-9 NVe5SXE4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVjPcFFCUUN3ME2yPE44QTZ7IN88US=> MkPNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
HL-60 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmnSTWM2OD1{Nz65PFY6KM7:TR?= MlLvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
QIMR-WIL MlrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFjuWYNKSzVyPUK3MlkyPDRizszN MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KARPAS-299 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFXPSmhKSzVyPUK2Mlg3PDZizszN MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KURAMOCHI NGH1c4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3WzWWlEPTB;Mk[uPFA5OiEQvF2= MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
BL-41 NUXmZm5pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4\6ZmlEPTB;MkWuPVU6PyEQvF2= NVXaR|JwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H2126 MkjLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MljOTWM2OD1{NT62OVI6KM7:TR?= M3H4NVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
HOP-62 M{XlUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrKNXFxUUN3ME2yOU41PDJ3IN88US=> NFjvT5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
IST-SL2 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mm\DTWM2OD1{ND61N|Q{KM7:TR?= MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
HH Mn7zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1[xTWlEPTB;MkSuN|gyQSEQvF2= M4jieVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LS-513 NVSxb4tYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1TxSmlEPTB;MkOuOVE4QSEQvF2= M2TFe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
EB-3 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoG2TWM2OD1{Mz6xPFMyKM7:TR?= NHLK[Io9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
ACN NYrZcXBGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGH5RZRKSzVyPUKxMlM{QDlizszN NVjpOYN7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NOMO-1 MlHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoLlTWM2OD1{MT6yNFA5KM7:TR?= M1O5OlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ES8 M4DNUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4fne2lEPTB;MkGuNFYh|ryP NETS[oE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
CESS MlrSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn64TWM2OD1{MD64OVQ6KM7:TR?= M1\5U|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
BL-70 MmmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTHTWM2OD1{MD6zNlc1KM7:TR?= M4\pPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MHH-PREB-1 MlXrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1nVV2lEPTB;MkCuNFM2PiEQvF2= Mly0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
BC-1 NEn0To5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGqxcHJKSzVyPUG5MlEyQThizszN M2rPXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LC4-1 M1PMUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MonwTWM2OD1zOD64O|M1KM7:TR?= MlT3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
COLO-320-HSR NFzCR3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NILpNGpKSzVyPUG4Mlc3QDhizszN NFTkc5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
A101D NV21SFZlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4\nWGlEPTB;MUiuN|IxQCEQvF2= M2DrO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
BC-3 NILVSHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEPhTnBKSzVyPUG4MlA{ODVizszN NID0N4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
TGW M1nvfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIq4cnBKSzVyPUG3MlgyOjRizszN NHPOSG49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
JAR M1HtPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVHjOIpDUUN3ME2xO{4xOTV{IN88US=> M3j6PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
HD-MY-Z NIXzTJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1nXcmlEPTB;MU[uPFI1PiEQvF2= NX\K[mJORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H1304 M2LafGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHLnVolKSzVyPUG2MlM3ODFizszN NX;SWFQ{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
OS-RC-2 M4PveGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUnoUIE1UUN3ME2xOU45Ozh{IN88US=> NHLGcWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
OCI-AML2 NG\oOoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NW\oemkzUUN3ME2xOU43PDh{IN88US=> Mk[1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
HCC1599 NYW4VFBET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF\ISVhKSzVyPUG0MlU6PzVizszN MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
SCC-3 NHPINodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mkj2TWM2OD1zND6yPVU3KM7:TR?= MlHiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
RPMI-6666 MoLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYP1OVZDUUN3ME2xN{46OTJzIN88US=> NEG5T4o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
MEG-01 M17oOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4XDZWlEPTB;MUOuPFM4QSEQvF2= MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
Raji NE\0T4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXrJR|UxRTF|Lke4PVQh|ryP NYG4[o1FRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
RPMI-8402 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mnu0TWM2OD1zMz62NlYzKM7:TR?= NUPyeZdvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
GCIY MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWX1VHdnUUN3ME2xNk45PjF|IN88US=> NFzXe5k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
697 MlrKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV3JR|UxRTF{Lk[wNFch|ryP NX7lVXhERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
D-247MG NFLKdnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnfsTWM2OD1zMj6zOVE3KM7:TR?= NX;zTWRWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NB1 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTF{LkOzNFgh|ryP NGjBbmk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
COR-L279 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XqSWlEPTB;MUKuNlkxPyEQvF2= NHjl[Y49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LB831-BLC NWLLZ3B{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4fh[mlEPTB;MUGuOVYzPCEQvF2= NWXVZWx{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
ST486 NH;EcVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkLZTWM2OD1zMD6zOVEh|ryP MnfnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
SK-UT-1 NHu3clRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXK4[GFYUUN3ME2xNE4{PSEQvF2= M4TQblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
BB65-RCC M3n0cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2C2SWlEPTB;OT65O|Q6PSEQvF2= M4fhflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
KARPAS-422 Mkm0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mle3TWM2OD17Lkm2N|M3KM7:TR?= MoTaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
Becker NYDTR5hZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHjFcpZKSzVyPUmuOFYxQDJizszN MmXDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
KS-1 NF;hSZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlLHTWM2OD17LkS1O|g2KM7:TR?= NX3vUlVzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
JiyoyeP-2003 M2jHc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRThwNUCyOlQh|ryP NFX4Sms9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCCIT NHP3SG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRTdwNUW0PFIh|ryP NXi4fmxpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
MRK-nu-1 NHnQdnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYrUdml2UUN3ME23MlEzQTZ7IN88US=> Mof2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
A3-KAW MlHHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWe5eFFSUUN3ME21Mlc3OTF4IN88US=> MlPnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
SK-N-MC NVjubmg5eUiWUzDhd5NigQ>? MVrxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= M4DPUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
LP-1 NWDp[FE1SXCxcITvd4l{KGG|c3H5 MV6zNEB2VQ>? Mn\iN{BpenN? MlPuTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCOUD2xJINmdGy|IHH0JFMxKHWPIHHmeIVzKDNiaILzJJV{cW6pIGTVUmVNKHO2YXnubY5oKGK7IH\sc5ch[3m2b33leJJ6 Mm\EQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
LP-1 MWPDfZRwfG:6aXPpeJkh[XO|YYm= M2PiWVIxKHSxIEOwJJVO M13l[lI1KGi{cx?= MmXoR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUHAuOSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gZ4VtdCC4aXHibYxqfHliYYSgNlAhfG9iM{CgeW0hfHKnYYTl[EBnd3JiMkSgbJJ{KG[xbHzve4VlKGK7IIfhd4hwfXRibXXhd5Vz\WRiYX\0[ZIhfG:2YXygO|IhcHK|IHfyc5d1cCCyZYLpc4Qh[WyjbXHyJIJtfWViYYPzZZkhemWuYYTpeoUhfG9iY3;ueJJwdA>? MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
LP-1 MoDPRZBweHSxc3nzJIF{e2G7 MX6zNEB2VQ>? MX2xMlUhcHK| NYjJ[|ZSUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDMVE0yKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDSUmEheG:ueX3ldoF{\SB{IIDoc5NxcG:|ZYLpcoUhOiCuZY\lcEBifCB|MDD1UUBi\nSncjCxMlUhcHK|IHL5JIludXWwb3Lsc5R1cW6p NH6yV409[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
LP-1 MXrBdI9xfG:|aYOgZZN{[Xl? MoW5N|AhfU1? NWTjVG5lOyCqcoO= NYe1WItOUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDMVE0yKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDNZ4wuOSCycn;0[YlvKGyndnXsJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KGK7IHntcZVvd2Kub4T0bY5o MnHRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
LP-1 MVPBdI9xfG:|aYOgZZN{[Xl? NUnZ[W9sOzBidV2= NY\HeYxuOyC2bzC1JIhzew>? Mn6yTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCOUD2xJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGyndnXsJI9nKGOuZXH2[YQhWEGUUDDheEA{OCC3TTDh[pRmeiB|IITvJFUhcHK|IHL5JIludXWwb3Lsc5R1cW6p M2LwWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 MnfLRZBweHSxc3nzJIF{e2G7 MnrhN|AhfU1? M13yclUhcHK| MofFTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDs[ZZmdCCxZjDjcIVifmWmIGDBVnAh[XRiM{CgeW0h[W[2ZYKgOUBpenNiYomgbY1ufW6xYnzveJRqdmd? M4nJV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 MYjBdI9xfG:|aYOgZZN{[Xl? NFfGeWM{OCC3TR?= NWPUTIJTOS53IHjydy=> M2[1bGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiZnHzeEB{dG:5IH3p[5JifGmwZzDofZBmenCqb4PwbI9zgWyjdHXkJHJPSSCyb3z5cYVz[XOnIELPJIZwem1iYYSgN|AhfU1iYX\0[ZIhOS53IHjyd{BjgSCrbX31co9jdG:2dHnu[y=> NF3xO4k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
RPM18226 NEO5UXNCeG:ydH;zbZMh[XO|YYm= MVezNEB2VQ>? MWixMlUhcHK| MVjJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKFKSTUG4NlI3KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDSUmEheG:ueX3ldoF{\SB{IIDoc5NxcG:|ZYLpcoUhOiCuZY\lcEBifCB|MDD1UUBi\nSncjCxMlUhcHK|IHL5JIludXWwb3Lsc5R1cW6p MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
RPM18226 NVG1WIFYSXCxcITvd4l{KGG|c3H5 M{L6[lMxKHWP NIrBc3o{KGi{cx?= MVnJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKFKSTUG4NlI3KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDNZ4wuOSCycn;0[YlvKGyndnXsJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KGK7IHntcZVvd2Kub4T0bY5o NWrKR5Z6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
RPM18226 NWLHdWlGSXCxcITvd4l{KGG|c3H5 NELGV4g{OCC3TR?= MnH4N{B1dyB3IHjydy=> MUjJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKFKSTUG4NlI3KGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHzleoVtKG:oIHPs[YF3\WRiUFHSVEBifCB|MDD1UUBi\nSncjCzJJRwKDViaILzJIJ6KGmvbYXuc4Jtd3S2aX7n NY\wUI9pRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 NXT4NYhPSXCxcITvd4l{KGG|c3H5 MlvyN|AhfU1? NUXFS4p[OyCqcoO= MXrJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKE6FST3IPVI6KGOnbHzzJIF{e2W|c3XkJIF{KGOqYX7n[ZMhcW5iWFnBVEBxem:2ZXnuJIxmfmWuIHH0JFMxKHWPIHHmeIVzKDNiaILzJIJ6KGmvbYXuc4Jtd3S2aX7n MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 Mo\VRZBweHSxc3nzJIF{e2G7 M4[2fVMxKHWP MnG2N{BpenN? M{jxe2lv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiY3jhcodmeyCrbjDzeZJ3cX[rbjDwdo91\WmwIHzleoVtKGG2IEOwJJVOKGGodHXyJFMhcHK|IHL5JIludXWwb3Lsc5R1cW6p NFu2bmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
RPM18226 NYXpbJd6SXCxcITvd4l{KGG|c3H5 Mn3lN|AhfU1? NFfDV2c{KGi{cx?= MVXJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKFKSTUG4NlI3KGOnbHzzJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KHW|aX7nJHRWVkWOIIP0ZYlvcW6pIHL5JIZtd3diY4n0c41mfHK7 MkfiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 NIPaU4pCeG:ydH;zbZMh[XO|YYm= MkjxN|AhfU1? NXq3dmdVOS53IHjydy=> M1TNNmlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJHJPSSCyb3z5cYVz[XOnIEKgdIhwe3Cqb4Pldolv\SB{IHzleoVtKGG2IEOwJJVOKGGodHXyJFEvPSCqcoOgZpkhcW2vdX7vZoxwfHSrbne= M3OzWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 M4HXNGFxd3C2b4Ppd{Bie3OjeR?= NHjEV28{OCC3TR?= MkO4NU42KGi{cx?= MoTnTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyCmZYDoc5NxcG:{eXzheIlwdiCxZjDwVoIh[XRiU{K0PU9VOjV{IHH0JFMxKHWPIHHmeIVzKDFwNTDodpMh[nliaX3teY5w[myxdITpcoc> Mn;6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 MXXDfZRwfG:6aXPpeJkh[XO|YYm= NEjwV3YzOCC2bzCzNEB2VQ>? M1;YOFE3KGi{cx?= MmPKR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUmNKNUh7MkmgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKGOnbHygeoli[mmuaYT5JIF1KDJyIITvJFMxKHWPIITy[YF1\WRiZn;yJFE3KGi{czDmc4xtd3enZDDifUB4[XOqb4X0JI1m[XO3cnXkJIFnfGW{IITveIFtKDd{IHjyd{Boem:5dHigdIVzcW:mIHHsZY1ieiCkbIXlJIF{e2G7IILlcIF1cX[nIITvJINwdnS{b3y= M4XiWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 NIfQfGhCeG:ydH;zbZMh[XO|YYm= MYCzNEB2VQ>? M2Hkb|MhcHK| MUXJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKE6FST3IPVI6KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDNZ4wuOSCycn;0[YlvKGyndnXsJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KGK7IHntcZVvd2Kub4T0bY5o M3zkcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 NXjyUmJJSXCxcITvd4l{KGG|c3H5 MVizNEB2VQ>? MUKzJIhzew>? M4HSbmlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiY3jhcodmeyCrbjDCZ4wuOiCycn;0[YlvKGyndnXsJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KGK7IHntcZVvd2Kub4T0bY5o NIHuOJI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
NCI-H929 Mmq2RZBweHSxc3nzJIF{e2G7 M{LkR|MxKHWP MVizJIhzew>? NEjXUpZKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG2IEOwJJVOKGGodHXyJFMhcHK|IIXzbY5oKFSXTlXMJJN1[WmwaX7nJIJ6KG[ub4egZ5l1d22ndIL5 MlT1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 M4XXVmFxd3C2b4Ppd{Bie3OjeR?= NH\RVYY{OCC3TR?= MofNNU42KGi{cx?= Ml3zTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gVm5CKHCxbInt[ZJie2ViMjDwbI9{eGixc3XybY5mKDVibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgNU42KGi{czDifUBqdW23bn;icI91fGmwZx?= MmDtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 NYrvWVNjSXCxcITvd4l{KGG|c3H5 NIPBd3A{OCC3TR?= NYLq[GFCOS53IHjydy=> M4DiXmlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJGhldTJibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgNU42KGi{czDifUBqdW23bn;icI91fGmwZx?= M33WSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 NXvk[4tlSXCxcITvd4l{KGG|c3H5 MnTSN|AhfU1? NIXTdnAyNjViaILz NIf1flRKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIH;mJJA2OyCjY3P1cZVt[XSrb36gZZQhOzBidV2gZYZ1\XJiMT61JIhzeyCkeTDpcY12dm:kbH;0eIlv\w>? NYm0eYtDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
SK-N-MC M1zNPJFJXFNiYYPzZZk> MV\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB6MEewN{c,OjFyOEC3NFM9N2F-
HCT116 MnmySpVv[3Srb36gZZN{[Xl? MoTSN|AhfG9iNECgeY1wdC:O MXiyOEBpenN? NHzG[YhKdmirYnn0bY9vKG:oIHP5Z4xqdiCDIHnuJIh2dWGwIFjDWFEyPiClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDwdo91\WmwIHzleoVtKGG2IEOwJJRwKDRyIIXtc4wwVCCjZoTldkAzPCCqcoOgZpkhcW2vdX7vZoxwfHSrbnegZY5idHm|aYO= Mn73QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFyOEC3NFMoRjJzMEiwO|A{RC:jPh?=
HCT116 M1j3bGZ2dmO2aX;uJIF{e2G7 M3zKNlMxKHSxIESwJJVud2xxTB?= MkTFNlQhcHK| MWrJcohq[mm2aX;uJI9nKGO7Y3zpckBDKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCycn;0[YlvKGyndnXsJIF1KDNyIITvJFQxKHWvb3yvUEBi\nSncjCyOEBpenNiYomgbY1ufW6xYnzveJRqdmdiYX7hcJl{cXN? MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB6MEewN{c,OjFyOEC3NFM9N2F-
HCT116 NVH4fmQzTnWwY4Tpc44h[XO|YYm= NIKxVoU{OCC2bzC0NEB2dW:uL1y= MWWyOEBpenN? NGfVe3NKdmirYnn0bY9vKG:oIHP5Z4xqdiCGMTDpckBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gdJJwfGWrbjDs[ZZmdCCjdDCzNEB1dyB2MDD1cY9tN0xiYX\0[ZIhOjRiaILzJIJ6KGmvbYXuc4Jtd3S2aX7nJIFv[Wy7c3nz NH3tNI09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC4NFcxOyd-MkGwPFA4ODN:L3G+
HCT116 M1jzb2Z2dmO2aX;uJIF{e2G7 NIjhUmo{OCC2bzC0NEB2dW:uL1y= M3TKSFI1KGi{cx?= NIn3PVlKdmirYnn0bY9vKG:oIFPET|IhcW5iaIXtZY4hUEOWMUG2JINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKHC{b4TlbY4hdGW4ZXygZZQhOzBidH:gOFAhfW2xbD;MJIFnfGW{IEK0JIhzeyCkeTDpcY12dm:kbH;0eIlv\yCjbnHsfZNqew>? NYTIXWllRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGwPFA4ODNpPkKxNFgxPzB|PD;hQi=>
HT-29 NFjFU|NHfW6ldHnvckBie3OjeR?= MkHONk42KHSxIESwJJVO NGLIUHAzPCCqcoO= NX\0UlRzUW6qaXLpeIlwdiCxZjDy[ZRqdm:kbHHzeI9u[SCycn;0[YlvKGmwIHj1cYFvKEiWLUK5JINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBw\iCleXPsbY4hSSCuZY\lcEBifCB{LkWgeI8hPDBidV2gZYZ1\XJiMkSgbJJ{KGK7IHntcZVvd2Kub4T0bY5o NV3I[29lRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
MCF7 M{TJeWNmdGxiY4njcIUh[XO|YYm= M4HlTVI1KGi{cx?= MUXD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KGGlY4XteYxifGmxbjDheEBIOi:PIIDoZZNmKGGodHXyJFI1KGi{czD1d4lv\yCycn;wbYRqfW1iaX;kbYRmKGGwZDDCdoRWKHO2YXnubY5oKGK7IH\sc5ch[3m2b33leJJ6 MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
RPMI8226 M3XaTGNmdGxiY4njcIUh[XO|YYm= NFjFVoszPCCqcoO= NVzOUmhsS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hWlCPSUiyNlYh[2WubIOgZZN{\XO|ZXSgZZMh[WOldX31cIF1cW:wIHH0JGczN01icHjhd4Uh[W[2ZYKgNlQhcHK|IIXzbY5oKHC{b4Dp[Il2dSCrb3Tp[IUh[W6mIFLy[HUhe3SjaX7pcoch[nliZnzve{BkgXSxbXX0dpk> NYHOflFuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
MCF7 M{D4c2NmdGxiY4njcIUh[XO|YYm= NHLL[WIzPCCqcoO= M2j5[2NmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJG1ETjdiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gV{BxcGG|ZTDj[YxtKHCxcIXsZZRqd25iYX\0[ZIhOjRiaILzJJV{cW6pIIDyc5Bq\Gm3bTDpc4Rq\GViYX7kJGJz\FVic4ThbY5qdmdiYomg[oxwfyCleYTvcYV1enl? NW\Db4h[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
MCF7 MWHD[YxtKGO7Y3zlJIF{e2G7 MXOyOEBpenN? MnexR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhe3WkLVexJJBp[XOnIHHmeIVzKDJ2IHjyd{B2e2mwZzDwdo9xcWSrdX2gbY9lcWSnIHHu[EBDemSXIIP0ZYlvcW6pIHL5JIZtd3diY4n0c41mfHK7 NHjBW|c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
RPMI8226 NV6yOW0{S2WubDDjfYNt\SCjc4PhfS=> MUSyOEBpenN? Mn;zR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gVnBOUTh{Mk[gZ4VtdHNiYYPz[ZN{\WRiYYOgZYNkfW23bHH0bY9vKGG2IIP1Zk1IOSCyaHHz[UBi\nSncjCyOEBpenNidYPpcocheHKxcHnkbZVuKGmxZHnk[UBidmRiQoLkWUB{fGGrbnnu[{BjgSCobH;3JIN6fG:vZYTyfS=> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
MCF7 NV;nRZdCS2WubDDjfYNt\SCjc4PhfS=> M37mWVgxKHWP MUWyOEBpenN? M1\4NmNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJG1ETjdiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJIFkfGm4ZXz5JJJmeGyrY3H0bY5oKESQQTDs[ZZmdCCjdDC4NEB2VSCjZoTldkAzPCCqcoOgeZNqdmdicILvdIllcXWvIHnv[Ill\SCjbnSgRpJlXSC|dHHpcolv\yCkeTDmcI94KGO7dH;t[ZRzgQ>? NXPSc45RRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
MCF7 MXrGeY5kfGmxbjDhd5NigQ>? M3\ZUlIxKHWP MW[yOEBpenN? MmD4TY5lfWO2aX;uJI9nKHB3Mz3k[ZBmdmSnboSgeJJidnOlcnnweIlwdmGuIHHjeIl3cXS7IHnuJIh2dWGwIF3DSlch[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4Uhd2ZicEKxJHdCTjFibHX2[Ywh[XRiMkCgeW0h[W[2ZYKgNlQhcHK|IHL5JIludXWwb3\seY9z\XOlZX7j[UBie3OjeR?= MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
RPMI8226 NUXPWIhkS2WubDDjfYNt\SCjc4PhfS=> MkHFNlQhcHK| MoT1R4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gVnBOUTh{Mk[gZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hWyCyaHHz[UBk\WyuIIDvdJVt[XSrb36gZYZ1\XJiMkSgbJJ{KHW|aX7nJJBzd3CrZHn1cUBqd2SrZHWgZY5lKEK{ZGWgd5RicW6rbnegZpkh\myxdzDjfZRwdWW2com= M4PQTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEG3OFE4Lz5{MUSxO|QyPzxxYU6=
RPMI8226 MkjWR4VtdCCleXPs[UBie3OjeR?= M2DlZVgxKHWP MVyyOEBpenN? M33vd2NmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJHJRVUl6MkK2JINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBw\iCjY4TpeoVtgSC{ZYDsbYNifGmwZzDEUmEhdGW4ZXygZZQhQDBidV2gZYZ1\XJiMkSgbJJ{KHW|aX7nJJBzd3CrZHn1cUBqd2SrZHWgZY5lKEK{ZGWgd5RicW6rbnegZpkh\myxdzDjfZRwdWW2com= M2jjUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEG3OFE4Lz5{MUSxO|QyPzxxYU6=
A549 MmHvRZBweHSxc3nzJIF{e2G7 M3T0T|IhfU1? NUH2blVUPDhiaILz MkToTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCDNUS5JINmdGy|IHHzd4V{e2WmIHHzJGRPSSCocnHncYVvfGG2aX;uJIF1KDJidV2gZYZ1\XJiNEigbJJ{KGK7IHHnZZJwe2ViZ3XsJIVt\WO2cn;wbI9z\XOrcx?= NIfreHk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{[yN|Q6OSd-MkO2NlM1QTF:L3G+
Sf9 NF7FdolHfW6ldHnvckBie3OjeR?= NIDIRXEyOCCvaX7z MX;Jcohq[mm2aX;uJI9nKEircz22MZRi\2enZDDy[YNwdWKrbnHueEBpfW2jbjDDSGszN2O7Y3zpcmUh\XiycnXzd4VlKGmwIHLhZ5Vtd3[rcoXzMYlv\mWldHXkJJNnQSClZXzsd{B2e2mwZzDobZN1d26nIFixJIF{KHO3YoP0doF1\SCjZoTldkAyOCCvaX7zJIJ6KGyrcYXp[EB{[2mwdHnscIF1cW:wIHPveY51cW6pIHnuJJBz\XOnbnPlJI9nKFupYX3tZU0{OlCfQWTQMEBKSzVyIE2gNE4yKM7:TT6= NH3Udmg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NESxO|U3Pid-MkS0NVc2PjZ:L3G+
BJ M3XtXmZ2dmO2aX;uJIF{e2G7 MoW3NVAhfU1? NIXRXZkyOCCmYYnz NInkeGFUfXCycnXzd4lwdiCxZjDz[Y5me2OnbnPlJIlvKGi3bXHuJGJLKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHPlcIwhdnWvYnXyJIF1KDFyIIXNJIFnfGW{IEGwJIRigXNiYomgd4Vv\XOlZX7j[UBz\X[ncoPhcEBie3OjeR?= NGTSW5E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[4NVk5Pid-MkS2PFE6QDZ:L3G+
BJ NEXoN3hHfW6ldHnvckBie3OjeR?= NFfzbIwyOCC3TR?= MWOxNEBl[Xm| MVXJcohq[mm2aX;uJI9nKGG2YYjpZUB1\Wyjbnfp[YN1[XOrYT3teZRifGWmIHnuJIh2dWGwIFLKJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGOnbHygcpVu[mW{IHH0JFExKHWPIHHmeIVzKDFyIHThfZMh[nlic3Xu[ZNk\W6lZTDy[ZZmenOjbDDhd5NigQ>? MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6MUm4Okc,OjR4OEG5PFY9N2F-
MCF7 MXzGeY5kfGmxbjDhd5NigQ>? MVexNEB2VQ>? NFLRfI8yOCCvaX7z MmLVV4Vve2m2aYrheIlwdiCxZjDpcoZz[XKnZD3pcoR2[2WmIFTORUBl[W2jZ3WgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ49td267IH\vdo1ifGmxbjDheEAyOCC3TTDwdoV1emWjdHXkJIZweiBzMDDtbY5{KG[xbHzve4VlKGK7IHnydoFlcWG2aX;uJIZweiB2IHjyd{Bu\WG|dYLl[EBi\nSncjCxNEBl[Xm|IHL5JINzgXO2YXygeolwdGW2IIP0ZYlvcW6pIHHuZYx6e2m| MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjh3MUWwOUc,OjZ6NUG1NFU9N2F-
Caco2 M3jWV2NmdGxiY4njcIUh[XO|YYm= Ml:3R4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gR4FkdzJiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEdzL2OgdIhie2ViYomgTI9m[2i|dDDzeIFqdmmwZzDiZZNm\CCobIXvdoV{[2WwY3WgZZN{[Xl? NX3PO|FCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyNVQzOzFpPkK4NlE1OjNzPD;hQi=>
HaCaT MUjD[YxtKGO7Y3zlJIF{e2G7 M2TOWGNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJGhiS2GWIHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMT;TJJBp[XOnIHL5JGhw\WOqc4Sgd5RicW6rbnegZoF{\WRiZnz1c5Jme2OnbnPlJIF{e2G7 NHL2NZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEKxOFI{OSd-MkiyNVQzOzF:L3G+
HuH7 NFrM[GZE\WyuIHP5Z4xmKGG|c3H5 NXTac4ZuS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hUHWKNzDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiR{GvV{BxcGG|ZTDifUBJd2WlaIP0JJN1[WmwaX7nJIJie2WmIH\seY9z\XOlZX7j[UBie3OjeR?= NH;je489[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEKxOFI{OSd-MkiyNVQzOzF:L3G+
PC3 MYLD[YxtKGO7Y3zlJIF{e2G7 NILOcJRE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBRSzNiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEd{L12gdIhie2ViYomgTI9m[2i|dDDzeIFqdmmwZzDiZZNm\CCobIXvdoV{[2WwY3WgZZN{[Xl? M4\pWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6MkG0NlMyLz5{OEKxOFI{OTxxYU6=
MDA-MB-231 MUTD[YxtKGO7Y3zlJIF{e2G7 NWjk[XZJS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hVUSDLV3CMVI{OSClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhTzFxUzDwbIF{\SCkeTDIc4VkcHO2IIP0ZYlvcW6pIHLhd4VlKG[udX;y[ZNk\W6lZTDhd5NigQ>? NX;XXVNoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyNVQzOzFpPkK4NlE1OjNzPD;hQi=>
HCT116 NG\UPIxE\WyuIHP5Z4xmKGG|c3H5 MU\D[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEdzL2OgdIhie2ViYomgTI9m[2i|dDDzeIFqdmmwZzDiZZNm\CCobIXvdoV{[2WwY3WgZZN{[Xl? M3vqUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6MkG0NlMyLz5{OEKxOFI{OTxxYU6=
SK-N-MC NW\4b2R3eUiWUzDhd5NigQ>? NFjRV21yUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1utUk1OSyClZXzsdy=> MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDV3N{SzNEc,Ojh3NUe0N|A9N2F-
A673 NEnxRWdyUFSVIHHzd4F6 MYjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? NHzwN|Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
DAOY M4rISpFJXFNiYYPzZZk> NWrmXIRleUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFTBU3kh[2WubIO= NWDnd4VxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 NWjxN2ZZeUiWUzDhd5NigQ>? MlLhdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEKWLUO3JINmdGy| Ml\zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SJ-GBM2 M17nfZFJXFNiYYPzZZk> NIjvdWRyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1qtS2JOOiClZXzsdy=> MnzQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
LAN-5 M4rIcZFJXFNiYYPzZZk> MVHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVEGQLUWgZ4VtdHN? NX7PV5VVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
SK-N-MC M2LTXZFJXFNiYYPzZZk> MV3xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= M4qzSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMUm5O|AzLz5|MEG5PVcxOjxxYU6=
Assay
Methods Test Index PMID
Western blot pT231-tau / pS202-tau / tau ; p-Rb / p-CDK2 / CDK2 / Cyclin D1 / Cyclin A2 / ERα / ERβ/ AIB1 / PELP1 30915013 21834972
Immunofluorescence CDK1 / Smek2 / FUBP1 / Cdc20 ; E2F1 / FASN / Bmi1 / Cyclin D2 / CDK2 / CDK4 24534090 20890301
Growth inhibition assay Cell viability 29996940
In vivo Roscovitine, at a dose of 50 mg/kg, significantly inhibits growth of The Ewing's sarcoma family of tumors (ESFT) xenografts. [4] Roscovitine enhances the antitumor effect of doxorubicin without increased toxicity with a mechanism that involves cell cycle arrest rather than apoptosis in nude mice bearing established MCF7 xenografts. [5]

Protocol (from reference)

Kinase Assay:[1]
  • Enzymes :

    Kinases activities are assayed at 30 °C in buffer C. Blank values are subtracted from the data and activities calculated as molar amount of phosphate incorporated in protein acceptor during a 10-minute incubation. Controls are performed with appropriate dilutions of DMSO. In a few cases, phosphorylation of the substrate is assessed by autoradiography after SDS/PAGE. p34cdc2/cyclin B is purified from M-phase starfish (M. glacialis) oocytes by affinity chromatography. It is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP (3000 Ci/mmol; 1 mCi/mL) in a final volume of 30 μL. After a 10-minute incubation at 30 °C, 25-μL aliquots of supernatant are spotted onto pieces of Whatman P81 phosphocellulose paper, and, after 20 seconds, the filters are washed five times (for at least 5 minutes each time) in a solution of 10mL phosphoric acid/L water. The wet filters are transferred into 6-mL plastic scintillation vials, 5 mL ACS scintillation fluid is added and the radioactivity measured in a Packard counter. The kinase activity is expressed as molar amount of phosphate incorporated in histone H1 during a 10-minutes incubation or as a percentage of maximal activity. p33cdk2/cyclin A and p33cdk2/cyclinE are reconstituted from extracts of sf9 insect cells infected with various baculoviruses. Cyclins A and E are fusion proteins with glutathione S-transferase and the complexes are purified on glutathione-agarose beads. Kinase activities are assayed with 1 mg/mL histone H1, in the presence of 15 μM [γ-32P]ATP, during 10 minutes, in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/p35 is purified from bovine brain, excluding the Mono S-chromatographic step. The active fractions from the Superose 12 column are pooled and concentrated to a final concentration of approximately 25 μg enzyme/mL. The kinase is assayed with 1 mg/mL histone HI in the presence of 15 μM [γ-32P]ATP, during 10 minutes in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/cyclin D1 is obtained from insect cell lysates. Cdk4 is a fusion protein with glutathione-S-transferase and the active complex is purified on glutathione-agarose beads. Its kinase activity is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. After a 15-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10 % SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. p33cdk4/cyclinD 2 is obtained from insect cell lysates. It is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. After a 30-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10% SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. MAP kinase erkl (tagged with glutathione-S-transferase), is expressed in bacteria, purified on glutathione-agarose beads and assayed with 1 mg myelin basic protein/ml in the presence of 15 μM [γ-32P]ATP as described above for the p34cdc2cyclin B kinase. His-tagged erkl and erk2 are activated in vitro by mitogen-activated protein kinase kinase, purified (Ni-affinity and Mono Q) and assayed as described above during 10 minutes in a final volume of 30 μL. Protein kinase C isoforms are purified from baculovirus infected sf9 insect cells and assayed with 1 mg/mL protamine sulfate in the presence of 15 μM [γ-32P]ATP, during 10 minutes at 30 °C, in a final volume of 30 μL. Phosphorylated protamine sulfate is recovered on Whatman P81 phosphocellulose paper as described for the cdc2 kinase. The catalytic subunit of cAMP-dependent protein kinase, purified from bovine heart, is assayed with 1 mg histone Hl/ml, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. cGMP-dependent protein kinase, purified to homogeneity from bovine tracheal smooth muscle, is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. Casein kinase 2 is isolated from rat liver cytosol and assayed with 1 mg casein/mL and 15 μM [γ-32P]ATP. The substrate is spotted on Whatmann 3MM filters and washed with 10% (mass/vol.) trichloroacetic acid. Myosin light chain kinase, purified from chicken gizzard is assayed in the presence of 100 nM calmodulin, 100 μM CaCl2, 50 mM Hepes, 5 mM MgCI,, 1 mM dithiothreitol and 0.1 mg BSA/ml at pH 7.5 using a synthetic peptide based on the smooth-muscle myosin light-chain phosphorylation site and in the presence of 15 μM [γ-32P]ATP, in a final volume of 50 μL. Incorporation of radioactive phosphate is monitored on phosphocellulose filters as described above. ASK-γ, a plant homologue of GSK-3, is expressed as a glutathione-S-transferase fusion protein in Escherichia coli and purified on glutathione-agarose. ASK-γ kinase is assayed, for 10 minutes at 30 °C, with 5 μg myelin basic protein, in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. The phosphorylated myelin basic protein is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. Insulin receptor tyrosine kinase domain (CIRK-41) is overexpressed in a baculovirus system and purified to homogeneity. Its kinase activity is assayed, for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. c-src kinase is purified from infected Sf9 cells. The v-abl kinase is expressed in E. coli and affinity purified on IgG Affigel 10. Both kinases are assayed for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase.

Cell Research:[1]
  • Cell lines: Leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer
  • Concentrations: 0.01 - 100 μM
  • Incubation Time: 48 hours
  • Method: 60 human tumour cell lines comprising nine tumor types are cultured for 24 hours prior to a 48-hour continuous exposure to 0.01-100 μM roscovitine. A sulforhodaminine B protein assay is used to estimate the cytotoxicity.
Animal Research:[4]
  • Animal Models: A4573 cells are injected s.c. into the right posterior flank of CD1 nu/nu mice.
  • Dosages: ≤50 mg/kg
  • Administration: Administered via i.p.

Solubility (25°C)

In vitro

DMSO 71 mg/mL
(200.31 mM)
Water Insoluble
Ethanol ''6 mg/mL

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+69% PEG 400
For best results, use promptly after mixing.

5mg/mL

Chemical Information

Molecular Weight 354.45
Formula

C19H26N6O

CAS No. 186692-46-6
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02649751 Terminated Drug: Roscovitine|Drug: Placebo Cystic Fibrosis University Hospital Brest|ManRos Therapeutics|Cyclacel Pharmaceuticals Inc. February 22 2016 Phase 2

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Frequently Asked Questions

Question 1:
How can I reconstitute the drug for in vivo studies?

Answer:
S1153 in 1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+PEG 400 is a clear solution which is okay for injection. And S1153 in 1% DMSO+30% polyethylene glycol+1% Tween 80 at 30mg/ml is a suspension, which is fine for oral gavage.

Tags: buy Roscovitine (CYC202) | Roscovitine (CYC202) supplier | purchase Roscovitine (CYC202) | Roscovitine (CYC202) cost | Roscovitine (CYC202) manufacturer | order Roscovitine (CYC202) | Roscovitine (CYC202) distributor